EVGN ▲ +11.1% - Evogene Ltd.
$EVGN EVGN - Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program
28-OCT-2026 08:31 AM ET
Share this post
More filings for $EVGN
EVGN ▼ -2.7% - Evogene Ltd.Oct 26, 2026EVGN ▼ -2.5% - Evogene Ltd.Oct 6, 2026EVGN ▲ +7.3% - Evogene Ltd.Sep 30, 2026EVGN ▲ +1.8% - Evogene Ltd.Aug 31, 2026EVGN - Evogene Ltd. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026EVGN - Evogene Ltd. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $EVGN filing history →💬 Comments
Loading comments…
Leave a comment